acetyl-l-carnitine as a precursor of acetylcholine The carnitine system and cancer metabolic plasticity Conceptual foundations of acetylcarnitine supplementation

In recent years there has been considerable interest in the therapeutic potential of L-carnitine and its acetylated derivative acetyl-L-carnitine (ALCAR) for neuroprotection in a number of disorders including hypoxia-ischemia, traumatic brain injury, Alzheimers disease and in conditions leading to central or peripheral nervous system injury

Chronic administration of high doses of oral levocarnitine in patients with severely compromised renal function or in ESRD patients on dialysis may result in accumulation of the potentially toxic metabolites, trimethylamine (TMA) and trimethylamine-N-oxide (TMAO), since these metabolites are normally excreted in the urine

end-systolic volume 25.5 +/- 3.2% vs

Cureus Journal of Medical Science Please note that by doing so you agree to be added to our monthly email newsletter distribution list